IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
407.00 USD   -0.19%
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overweight Rating
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Idexx: 4Q Earnings Snapshot

02/02/2021 | 06:49am EDT

WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Tuesday reported fourth-quarter earnings of $174.8 million.

The Westbrook, Maine-based company said it had net income of $2.01 per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.43 per share.

The Animal diagnostic and health care company posted revenue of $720.9 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $681.5 million.

For the year, the company reported profit of $581.8 million, or $6.71 per share. Revenue was reported as $2.71 billion.

Idexx expects full-year earnings to be $7.39 to $7.71 per share, with revenue in the range of $3.07 billion to $3.12 billion.

Idexx shares have decreased 1.5% since the beginning of the year. The stock has risen 74% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about IDEXX LABORATORIES, INC.
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates ..
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overw..
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Over..
MT
08/03Atlantic Equities Adjusts Price Target on IDEXX Laboratories to $490 From $500, Reitera..
MT
08/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
08/02WALL STREET STOCK EXCHANGE : Pelosi’s expected Taiwan visit spooks markets
MS
08/02SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Tuesday
MT
08/02TRANSCRIPT : IDEXX Laboratories, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02IDEXX Laboratories Q2 Profit Declines While Revenue Rises; Lowers Full-Year 2022 Outloo..
MT
08/02IDEXX LABORATORIES : Announces Second Quarter Results - Form 8-K
PU
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 382 M - -
Net income 2022 687 M - -
Net Debt 2022 1 126 M - -
P/E ratio 2022 50,3x
Yield 2022 -
Capitalization 34 191 M 34 191 M -
EV / Sales 2022 10,4x
EV / Sales 2023 9,55x
Nbr of Employees 10 350
Free-Float 77,1%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 407,00 $
Average target price 477,00 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-38.07%34 191
ABBOTT LABORATORIES-22.37%190 883
MEDTRONIC PLC-9.83%124 341
STRYKER CORPORATION-18.73%82 217
BECTON, DICKINSON AND COMPANY4.15%73 001
HOYA CORPORATION-15.34%38 786